MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy

Although TP53 mutations are rare in acute myeloid leukemia (AML), inactivation of wild-type p53 protein frequently occurs through overexpression of its negative regulator MDM2 (murine double minute 2). Recently, small-molecule antagonists of MDM2, Nutlins, have been developed that inhibit the p53-MD...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kojima, Kensuke, Konopleva, Marina, Samudio, Ismael J., Shikami, Masato, Cabreira-Hansen, Maria, McQueen, Teresa, Ruvolo, Vivian, Tsao, Twee, Zeng, Zhihong, Vassilev, Lyubomir T., Andreeff, Michael
Формат: Artigo
Язык:Inglês
Опубликовано: The American Society of Hematology 2005
Предметы:
Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895324/
https://ncbi.nlm.nih.gov/pubmed/16014563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-02-0553
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы